Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
NCT01421303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2014-12-12
Summary
Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.
Conditions
Interventions
- DRUG
-
Enbrel
Enbrel
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
NCT00544557 ·Status: COMPLETED
-
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
NCT00420238 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
NCT00421915 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
NCT01877239 ·Status: COMPLETED
-
An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
NCT00421980 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
NCT00873730 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study Evaluating Etanercept in Ankylosing Spondylitis
NCT00410046 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
NCT02638896 ·Status: UNKNOWN ·Phase: PHASE4
-
Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
NCT00844142 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
NCT00247962 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
NCT02486302 ·Status: COMPLETED
-
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
NCT01411215 ·Status: TERMINATED
-
Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
NCT02202837 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
NCT01258738 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
NCT01934933 ·Status: COMPLETED ·Phase: PHASE4
-
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Evaluation of the Radiographic Efficacy of Enbrel
NCT01623752 ·Status: COMPLETED
-
Study Evaluating Etanercept in Patients With Ankylosing Spondylitis
NCT00458185 ·Status: COMPLETED ·Phase: PHASE4
-
Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis
NCT03880968 ·Status: COMPLETED
-
Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
NCT00132418 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
NCT02322580 ·Status: COMPLETED
-
Study Investigating Enbrel Treatment for Ankylosing Spondylitis
NCT00195416 ·Status: COMPLETED
-
Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
NCT00418548 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED